Genentech Halts Avastin Approval Filing for Mesothelioma
In 2015, data was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from a Phase III French study that demonstrated improved survival
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
In 2015, data was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from a Phase III French study that demonstrated improved survival
The April 2017 issue of Translational Lung Cancer Research features an article titled Immunotherapy and radiation therapy for malignant pleural mesothelioma written by a group
Michele Carbone, MD, PhD, Director of Thoracic Oncology at the University of Hawaii (UH) Cancer Center, along with his team, have discovered why people carrying
The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, had the
On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II
This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results
Getting stepped down to the floor was a very nice change from the ICU. For one thing, I was feeling better. That was the whole
In complete contradistinction to the ambiguity of the long white coat, you, dear patient, are wearing something that tells the entire world precisely who you